IDEAS home Printed from https://ideas.repec.org/a/ids/ijbire/v39y2026i2p129-160.html

Innovative healthcare product design and financial returns: evidence from an Indian pharmaceutical company

Author

Listed:
  • Mithun Nandy

Abstract

The case focuses on Glenmark Pharmaceuticals Limited's innovative marketing strategy behind the launch of a contemporary healthcare brand 'FabiFlu', the generic version of Japanese anti-influenza drug Favipiravir for the treatment of novel coronavirus infections. There are two dimensions to the novelty of this case. This case discusses Glenmark's clinical trials and innovative activities that enabled them to launch India's first COVID-19 drug. Additionally, the case illustrates how FabiFlu captured the number one spot in the domestic Indian pharmaceutical market in April 2021, with sales of 3.5 billion, and was recognised as the top-selling brand in the Indian pharmaceutical retail market. The study also provides some insight into how to deal with time-series data concerning trend analysis of the R%D investment of the sample company incorporated in this case study.

Suggested Citation

  • Mithun Nandy, 2026. "Innovative healthcare product design and financial returns: evidence from an Indian pharmaceutical company," International Journal of Business Innovation and Research, Inderscience Enterprises Ltd, vol. 39(2), pages 129-160.
    • Handle: RePEc:ids:ijbire:v:39:y:2026:i:2:p:129-160
    as

    Download full text from publisher

    File URL: http://www.inderscience.com/link.php?id=152076
    Download Restriction: Access to full text is restricted to subscribers.
    ---><---

    As the access to this document is restricted, you may want to

    for a different version of it.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ids:ijbire:v:39:y:2026:i:2:p:129-160. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sarah Parker (email available below). General contact details of provider: http://www.inderscience.com/browse/index.php?journalID=203 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.